ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,472,943 | -91.9% | 164,810 | -90.9% | 0.01% | -91.7% |
| Q2 2023 | $55,535,530 | +129.2% | 1,806,621 | +168.6% | 0.11% | +111.8% |
| Q1 2023 | $24,231,256 | +39.5% | 672,530 | +55.6% | 0.05% | +34.2% |
| Q3 2022 | $17,368,000 | +496.8% | 432,250 | +479.0% | 0.04% | +533.3% |
| Q1 2022 | $2,910,000 | -61.7% | 74,655 | -60.9% | 0.01% | -57.1% |
| Q4 2021 | $7,605,000 | -82.5% | 190,846 | -84.1% | 0.01% | -92.2% |
| Q3 2021 | $43,440,000 | +3428.8% | 1,201,980 | +4008.6% | 0.18% | +2150.0% |
| Q3 2020 | $1,231,000 | – | 29,255 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |